Search

everythinglearnresearchcommunity

for

Search:↓

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Humans lost body hair relatively recently in evolution.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Some vaccines might rarely cause hair loss, more research is needed.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Some birth control pills have a higher risk of blood clots than others.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Higher iron levels in the blood are not linked to increased hair loss in women.

K16 can partially replace K14 but causes hair loss and skin issues.